Venrock Healthcare Capital Partners II L.P. 13D and 13G filings for aTyr Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:07 pm Sale |
2022-12-31 | 13G | aTyr Pharma, Inc. ATYR |
Venrock Healthcare Capital Partners II L.P. | 1,171,436 4.000% |
-393,564 (-25.15%) |
Filing |
| 2022-02-14 4:17 pm Sale |
2021-12-31 | 13G | aTyr Pharma, Inc. ATYR |
Venrock Healthcare Capital Partners II L.P. | 1,565,000 5.600% |
-250,000 (-13.77%) |
Filing |
| 2021-09-27 5:14 pm Purchase |
2021-09-16 | 13G | aTyr Pharma, Inc. ATYR |
Venrock Healthcare Capital Partners II L.P. | 1,815,000 6.700% |
1,815,000 (New Position) |
Filing |